Breast Reconstruction Clinical Trial
Official title:
A Prospective Multicenter Study of the Safety and Effectiveness of NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-filled X-style and L-style Breast Implants
Verified date | June 2020 |
Source | Allergan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a prospective, multicenter study of the safety and effectiveness of NATRELLE® 410 Highly Cohesive, Anatomically Shaped, Silicone-Filled X-Style and L-Style Breast Implants.
Status | Terminated |
Enrollment | 355 |
Est. completion date | November 30, 2015 |
Est. primary completion date | November 30, 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: For entry in this study, participants must have been enrolled in the 410 Continued Access (CA) Clinical Study or 410 Continued Access Reconstruction/Revision Expansion (CARE) Clinical Study under the inclusion criteria listed below and received NATRELLEĀ® 410 Highly Cohesive, Anatomically Shaped, Silicone-Filled X-Styles or L-Styles breast implants - Female, age 18 or older - Present with 1 or more of the following conditions: 1. Primary breast augmentation (i.e., no previous breast implant surgery) indicated for subject dissatisfaction with size or shape of breast (e.g., mammary hypoplasia), asymmetry, ptosis, or aplasia 2. Primary breast reconstruction (i.e., no previous breast implant surgery other than implantation of tissue expanders or contralateral augmentation for asymmetry) indicated, in the affected breast, for mastectomy for cancer, prophylactic mastectomy, or breast trauma (resulting in mastectomy) and for the unaffected breast, contralateral asymmetry (may be performed on the date of the mastectomy or the date when the permanent implants are placed in the reconstructed breast) 3. Breast implant revision surgery (i.e., removal and replacement of breast implants) indicated for previous augmentation or reconstruction with silicone-filled or saline-filled breast implants - Has adequate tissue available to cover implants - Willing to undergo magnetic resonance imaging (MRI) at the specified follow-up visits for subjects at MRI designated sites and be eligible for MRI (e.g., no implanted metal or metal devices, no history of severe claustrophobia) Exclusion Criteria: For entry in this study, participants must have been enrolled in the 410 CA Clinical Study or 410 CARE Clinical Study, meeting the exclusion criteria listed below, did not receive any NATRELLEĀ® 410 Highly Cohesive, Anatomically Shaped, Silicone-Filled FM, FF, MM, or MF Style Breast Implants, and have not undergone implant removal with or without replacement surgery - Does not have advance fibrocystic disease considered to be premalignant without accompanying subcutaneous mastectomy - Does not have existing carcinoma of the breast, without mastectomy - Does not have abscess or infection in the body at the time of enrollment - Is not pregnant or nursing - Does not have any disease, including uncontrolled diabetes (e.g., hemoglobin A1c (HbA1c) > 8%), that is clinically known to impact wound healing ability - Does not show tissue characteristics that are clinically incompatible with mammaplasty, such as tissue damage resulting from radiation inadequate tissue, compromised vascularity, or ulceration - Does not have or is under treatment for any condition that may constitute an unwarranted surgical risk (e.g., unstable cardiac or pulmonary problems) - Does not show psychological characteristics that may be incompatible with the surgical procedure and the prosthesis, such as inappropriate attitude or motivation (e.g., body dysmorphic disorder) - Is not willing to undergo further surgery for revision, if medically required |
Country | Name | City | State |
---|---|---|---|
United States | Walter Erhardt | Albany | Georgia |
United States | James Namnoum | Atlanta | Georgia |
United States | Peter Hyans | Berkeley Heights | New Jersey |
United States | Laurence Berkowitz | Campbell | California |
United States | Janet Turkle | Carmel | Indiana |
United States | Charles Nathan | Chesterfield | Missouri |
United States | Herluf Jr. Lund | Chesterfield | Missouri |
United States | Raymond Isakov | Cleveland | Ohio |
United States | Gregory Liebscher | Colorado Springs | Colorado |
United States | Patricia McGuire | Creve Coeur | Missouri |
United States | John Renucci | Grand Rapids | Michigan |
United States | Tracy Pfeifer | Great Neck | New York |
United States | Jeffrey Friedman | Houston | Texas |
United States | Peter Hetzler | Little Silver | New Jersey |
United States | Julene Samuels | Louisville | Kentucky |
United States | Steven Morris | Midland | Michigan |
United States | Timothy Mickel | Monroe | Louisiana |
United States | Mary Gingrass | Nashville | Tennessee |
United States | Patrick Maxwell | Nashville | Tennessee |
United States | Lloyd Gayle | New York | New York |
United States | Thomas Blanchard | Newport News | Virginia |
United States | Perry Johnson | Omaha | Nebraska |
United States | Calvin Peters | Orlando | Florida |
United States | Roy Hong | Palo Alto | California |
United States | Eric Bachelor | Pleasanton | California |
United States | Caroline Glicksman | Sea Girt | New Jersey |
United States | Craig Colville | Toledo | Ohio |
United States | Frank Barone | Toledo | Ohio |
United States | Scott Spear | Washington | District of Columbia |
Lead Sponsor | Collaborator |
---|---|
Allergan |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage of Participants According to Investigator Satisfaction With Implants | The investigator rated their satisfaction with the participant's breast implant for each breast on a 5-point scale (1=Definitely dissatisfied, 2=Somewhat dissatisfied,3=Neither satisfied or dissatisfied, 4=Somewhat satisfied, 5=Definitely satisfied). If there was a different response for the left and right breasts the worst response was used. The percentage of participants where the investigator responded: "Definitely satisfied" or "Somewhat satisfied" is reported. | 3 years (followup after implantation that occurred between 07 July 2009 and 01 January 2012) | |
Primary | Percentage of Participants According to Participant Satisfaction With Implants | The participant rated their satisfaction with the breast implant for each breast on a 5-point scale (1=Definitely dissatisfied, 2=Somewhat dissatisfied, 3=Neither satisfied or dissatisfied, 4=Somewhat satisfied, 5=Definitely satisfied). If there was a different response for the left and right breasts the worst response was used. The percentage of participants who responded: "Definitely satisfied" or "Somewhat satisfied" is reported. | 3 years (followup after implantation that occurred between 07 July 2009 and 01 January 2012) | |
Secondary | Percentage of Participants With Local Complications | Kaplan-Meier risk rates (estimation of the percentage of participants) of developing local complications is presented. Local complications collected in the study were: Asymmetry, Breast Pain, Capsular contracture, Delayed wound healing, Fluid accumulation/seroma, Implant malposition, Implant palpability/visibility. Implant rupture, Infection, Ptosis, Redness, Swelling, Wrinkling/rippling and Other complications (calcifications on mammogram, thing of mastectomy flap, deformity and nipple stretching). | 5 years (followup after implantation that occurred between 07 July 2009 and 01 January 2012) | |
Secondary | Percentage of Participants With Reoperations | Kaplan-Meier risk rates (estimation of the percentage of participants) of reoperation is reported. | 5 years (followup after implantation that occurred between 07 July 2009 and 01 January 2012) | |
Secondary | Percentage of Participants With Implant Removal With or Without Replacement | Kaplan-Meier risk rates (estimation of the percentage of participants) of implant removal with or without replacement | 5 years (followup after implantation that occurred between 07 July 2009 and 01 January 2012) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03757793 -
Near-infrared Spectroscopy for Monitoring Tissue Oxygenation in Breast Reconstruction
|
||
Completed |
NCT05491473 -
Negative Pressure in PAP Donor Sites
|
||
Not yet recruiting |
NCT06013514 -
Post-market Prospective Clinical Study of Nagor Perle Mammary Implants
|
||
Completed |
NCT02169011 -
Secondary Breast Reconstruction With a Flap of Skin From the Back
|
N/A | |
Completed |
NCT01216319 -
Evaluation of the Cook Biodesign Plastic Surgery Matrix
|
N/A | |
Completed |
NCT01176786 -
Reusable Versus Disposable Draping System in Breast Reconstruction Surgery
|
N/A | |
Not yet recruiting |
NCT00973544 -
Do Closed Suction Drains Affect the Complications Rate of Breast Reconstruction With Silicone Prosthesis?
|
N/A | |
Active, not recruiting |
NCT00748722 -
Pre-Operative Imaging of Abdominal Wall Perforators Using CT Angiography
|
N/A | |
Completed |
NCT00753922 -
Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Silicone Gel-filled Mammary Prostheses
|
Phase 3 | |
Completed |
NCT05897463 -
Nipple Neurotization
|
||
Recruiting |
NCT05377723 -
Abdominal Scar Improvement in Microsurgical Breast Reconstruction
|
N/A | |
Completed |
NCT04350411 -
Comparison of PEAK PlasmaBladeā¢ to Conventional Diathermy in Abdominal Based Free Flap Breast Reconstruction
|
N/A | |
Completed |
NCT06321549 -
New Era of DIEP With Minimally Invasive Mastectomy
|
||
Withdrawn |
NCT03135392 -
Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer
|
N/A | |
Completed |
NCT01256502 -
The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery
|
N/A | |
Active, not recruiting |
NCT04715802 -
Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel
|
||
Active, not recruiting |
NCT04491591 -
Implementing BREASTChoice Into Practice
|
N/A | |
Recruiting |
NCT04661501 -
BREAST ADM Trial for Alloplastic Breast Reconstruction
|
N/A | |
Suspended |
NCT03625765 -
Integrated Imaging System for In Vivo Visualization of Free Flap Perfusion Using Indocyanine Dye
|
N/A | |
Withdrawn |
NCT00778947 -
Single Centre Study to Compare Harmonic Scalpel to Conventional Diathermy in Free Tissue Transfer Breast Reconstruction
|
N/A |